Belite Bio, Inc (NASDAQ:BLTE) Q1 2026 Earnings Call Transcript
Belite Bio, Inc (NASDAQ:BLTE) Q1 2026 Earnings Call Transcript May 20, 2026Belite Bio, Inc beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.6.
Belite Bio Inc (BLTE)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Darwin Global Management Abhishek Trehan | 3,077,219 | $456,588,244 | +1% | 12.14% |
| 2. | Paradigm Biocapital Advisors Senai Asefaw | 1,232,877 | $189,844,565 | +11% | 3.55% |
| 3. | Millennium Management Israel Englander | 494,564 | $76,155,438 | -14% | 0.03% |
| 4. | Maverick Capital Lee Ainslie | 396,311 | $61,025,949 | 0.54% | |
| 5. | Deerfield Management James E. Flynn | 357,199 | $55,003,288 | +18% | 0.57% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $198.09 | 2,700 | $534,844.89 | 70,134 | 2026-09-08 | Filing | |
| $197.36 | 8,752 | $1,727,274.59 | 72,834 | 2026-09-08 | Filing | |
| $196.54 | 6,058 | $1,190,642.35 | 81,586 | 2026-09-08 | Filing | |
| $195.62 | 6,090 | $1,191,325.19 | 87,644 | 2026-09-08 | Filing | |
| $194.33 | 2,400 | $466,398.72 | 93,734 | 2026-09-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 715,332 | $110,150,398 | 0.94% | |
| 2. | 390,829 | $60,181,804 | 0.8% | |
| 3. | 235,071 | $36,197,407 | 0% | |
| 4. | 224,989 | $34,644,931 | 0% | |
| 5. | 166,188 | $25,590,459 | 0% |
News See All
10 Best Up and Coming Stocks with Highest Upside Potential
In this article, we will discuss the 10 Best Up and Coming Stocks with Highest Upside Potential.
Belite Bio, Inc (NASDAQ:BLTE) Q4 2025 Earnings Call Transcript
Belite Bio, Inc (NASDAQ:BLTE) Q4 2025 Earnings Call Transcript March 3, 2026 Operator: Ladies and gentlemen, thank you for joining us, and welcome to the Belite Bio Fourth Quarter and Fiscal Year-End ...
Belite Bio, Inc (NASDAQ:BLTE) Q3 2025 Earnings Call Transcript
Belite Bio, Inc (NASDAQ:BLTE) Q3 2025 Earnings Call Transcript November 10, 2025Belite Bio, Inc misses on earnings expectations. Reported EPS is $-0.65 EPS, expectations were $-0.53.
Hedge Fund Resource Center